Ascendis Pharma ADR (ASND)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ASND | LEGN | PCVX | ||
| Company | Ascendis Pharma ADR | Legend Biotech Corp ADR | Vaxcyte Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 133.62 | 45.65 | 65.20 | ||
| High | 135.84 | 45.70 | 66.71 | ||
| Low | 132.59 | 42.96 | 64.76 | ||
| Last | 133.46 | 43.24 | 65.19 | ||
| Change | +0.33 | -2.28 | -0.38 | ||
| % Change | +0.25% | -5.01% | -0.58% | ||
| Volume | 218,271 | 887,583 | 533,487 | ||
| 20-Day Average Volume | 319,329 | 1,114,494 | 705,174 | ||
| Previous Close | 133.13 | 45.52 | 65.57 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 139.07 | 46.17 | 62.97 | ||
| 20-Day Raw Stochastic | 4.94% | 10.15% | 70.06% | ||
| 20-Day Relative Strength | 40.56% | 31.35% | 50.73% | ||
| Weighted Alpha | +40.16 | -44.50 | +31.66 | ||
| Today's Opinion | 8% Buy | 100% Sell | 24% Buy | ||
| Previous Opinion | 8% Buy | 100% Sell | 24% Buy | ||
| Last Month's Opinion | 100% Buy | 88% Sell | 24% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -2.73% since 05/03/24 | -4.78% since 05/03/24 | -1.17% since 05/03/24 | ||
| Low | 132.59 on 05/10/24 | 42.96 on 05/10/24 | 63.63 on 05/09/24 | ||
| High | 138.36 on 05/06/24 | 46.40 on 05/07/24 | 68.22 on 05/08/24 | ||
| 1-Month | |||||
| %Chg | -12.53% since 04/10/24 | -22.08% since 04/10/24 | +4.24% since 04/10/24 | ||
| Low | 132.59 on 05/10/24 | 42.08 on 05/01/24 | 58.10 on 04/25/24 | ||
| High | 154.41 on 04/11/24 | 55.62 on 04/11/24 | 68.22 on 05/08/24 | ||
| 3-Month | |||||
| %Chg | -5.85% since 02/09/24 | -29.08% since 02/09/24 | -12.86% since 02/09/24 | ||
| Low | 132.59 on 05/10/24 | 42.08 on 05/01/24 | 58.10 on 04/25/24 | ||
| High | 161.00 on 02/26/24 | 70.13 on 02/27/24 | 82.04 on 02/28/24 | ||
| 6-Month | |||||
| %Chg | +47.83% since 11/10/23 | -32.89% since 11/10/23 | +35.42% since 11/10/23 | ||
| Low | 86.54 on 11/13/23 | 42.08 on 05/01/24 | 46.16 on 11/13/23 | ||
| High | 161.00 on 02/26/24 | 70.13 on 02/27/24 | 82.04 on 02/28/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 7,751,360 | 8,280,589 | 7,108,312 | ||
| Shares Outstanding, K | 58,224 | 181,911 | 108,408 | ||
| Annual Sales | 288,670,000 | 285,140,000 | 0 | ||
| Annual Net Income | -521,070,000 | -518,250,000 | -402,270,000 | ||
| Last Quarter Sales | 104,110,000 | 79,460,000 | 0 | ||
| Last Quarter Net Income | -142,260,000 | -144,820,000 | -180,800,000 | ||
| 60-Month Beta | 0.54 | 0.12 | 0.94 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -2.48 on 05/02/24 | -0.40 on 03/11/24 | -0.85 on 05/08/24 | ||
| Latest Earnings Date | 05/02/24 | 05/13/24 | 05/13/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||